539871 Share Price Performance
₹466.35
129.17 (38.31%)
22.3% undervalued intrinsic discount
₹600.00
Fair Value
Price ₹466.35
AnalystConsensusTarget ₹600.00
Fair Value₹600.00
Share Pricen/a
Narrative Update • May 18
Thyrocare Technologies Limited Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 6 Fair Values set on narratives written by author
539871 Community Narratives
AN
Fair Value
·Fair Value ₹600 22.3% undervalued intrinsic discount
Upcoming Bonus Shares And Dividend Proposal Will Drive Shareholder Value
0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
Upcoming Bonus Shares And Dividend Proposal Will Drive Shareholder Value
Thyrocare is pushing deeper into smaller Indian cities and adding new types of diagnostic tests, which could bring in more customers and improve profitability as the network scales. But its growth also leans on partners and franchises it doesn’t fully control, and fast-moving at-home testing tech could weaken demand for large central labs.Read more
AN
₹600
22.3% undervalued intrinsic discount
Fair Value
Revenue
17.1% p.a.
Profit Margin
22.24%
Future PE
44.17x
Price in 2029
₹850.51
Trending Discussion
Recently Updated Narratives
AN
539871: Expanded Healthcare Mandate Will Support Bullish Medium Term View
Fair Value: ₹600 22.3% undervalued intrinsic discount
4 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Thyrocare Technologies Limited Key Details
About 539871
- Founded
- 1996
- Employees
- 1822
- CEO
- WebsiteView website
Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates through three segments: Diagnostic Testing Services, Imaging Services, and Others. The Diagnostic Testing Services segment engages in the selling of consumables used for collection, and promotion of pathology. The Imaging Services segment sells radio-pharmaceutical and consumables for reporting. The Others segment engages in the sale of testing equipment and consumables; and glucometer and glucostrips under the brand name sugarscan. The company offers diagnostic and pathological services. The company was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.
